Latest

Health

·April 16, 2020·3 min read

Proteins may halt the severe cytokine storms seen in COVID-19 patients

Researchers have designed antibody-like receptor proteins that can bind to cytokines, possibly reducing the effects of the COVID-19 associated cytokine storm.

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Development of antibody research may help prevent sepsis induced by COVID-19

Researchers have developed a novel antibody strategy to prevent the association between a harmless protein and a disease mediator that could lead to sepsis, and ultimately death. The findings could help to prevent sepsis induced by COVID-19 infections.

This shows a woman in a facemask holing a flower

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Study identifies 275 ways to reduce spread of coronavirus following lockdown

Study identifies 275 ways to help reduce the transmission of COVID-19 when countries eventually attempt to reduce social distancing pract

Featured Neuroscience Open Neuroscience Articles

·April 15, 2020·4 min read

COVID-19: Exercise may protect against deadly complication

Regular exercise may help prevent or reduce the severity of ARDS for those with coronavirus. A single session of exercise increases the production of a critical antioxidant, called EcSOD, helping to reduce the effects of COVID-19 infection.

This is a drawing of a person coughing in the chamber

Featured Neuroscience Neuroscience Videos

·April 15, 2020·3 min read

COVID-19: ‘Cough chamber’ shows six-feet not far enough

Droplets from a cough travel at a speed of 1.2 meters per second at peak velocity. Findings reveal that there is no logical reason to suggest 6 foot of physical distance is substantial at reducing coronavirus transmission.

Featured Neuroscience

·April 14, 2020·4 min read

Targeting cell’s own machinery in fight against COVID-19

Coronaviruses rely on the TOP3B enzyme as a host factor, researchers report. Using artificial intelligence and molecular modeling, researchers were able to identify drug candidates that could serve as TOP3B inhibitors. Studies are now underway to test the drug candidates against living cell cultures and viruses, including COVID-19.

This shows covid19 and a depressed woman

Featured Neurology Neuroscience Open Neuroscience Articles Psychology

·April 14, 2020·4 min read

In wake of COVID-19 pandemic, a crashing wave of neuropsychiatric problems?

Reviewing data from past pandemics, researchers suggest some of those exposed to COVID-19 could have an increased risk of developing neurological and mental health disorders in the long term. Acute viral infections can result in encephalopathy, psychosis, depression, demyelination disorders, and problems with neuromuscular function.

This shows the interaction between dpp4 and covid19

Featured Genetics Neuroscience Open Neuroscience Articles

·April 13, 2020·2 min read

Could inhibiting the DPP4 enzyme help treat coronavirus?

Previous studies of related coronaviruses SARS and MERS found blocking DPP4 activity reduced inflammatory response. Researchers suggest drugs that target DPP4 could help to reduce the overexpression of inflammatory cytokines seen in severe COVID-19.

Featured Neuroscience

·April 13, 2020·4 min read

Remdesivir effective against a key enzyme of coronavirus that causes COVID-19

Remdesivir, a drug initially developed to fight Ebola and currently being fast-tracked into trials for COVID-19, is highly effective at stopping the replication mechanism of coronavirus. The drug tricks the virus by mimicking its building blocks, causing the inhibitor to get incorporated repeatedly, and preventing replication of SARS-CoV-2.

Featured Neuroscience Open Neuroscience Articles

·April 13, 2020·2 min read

Mandated TB vaccination predicts flattened curves for COVID-19 spread

Researchers report that if the US had adopted mandatory BCG vaccines against tuberculosis decades ago, we may not have reached death rates in triple digits for coronavirus. Countries that have a current policy mandating BCG vaccinations have significantly slower growth of both COVID-19 cases and deaths compared to countries with no mandates for the TB vaccination.

Featured Neuroscience

·April 13, 2020·4 min read

Loss of smell and taste validated as COVID-19 symptoms in patients with high recovery rate

Study confirms sensory loss associated with taste and smell is strongly linked to early coronavirus infection. Based on the findings, people who report olfactory or taste loss are ten times more likely to have COVID-19 than other infections. Patients reported their sensory loss to be profound rather than mild. Encouragingly, the rate of sensory recovery was high, with patients reporting a return of normal smell and taste function within two to four weeks, which matches the time of disease recovery. Researchers also found people who reported sore throats more often tested negative for COVID-19.

$This shows the earth covered with the covid19 spikes$

Featured Neuroscience Open Neuroscience Articles

·April 13, 2020·6 min read

Mathematical modeling draws more accurate picture of coronavirus cases

A new mathematical model reveals a more realistic picture of the number of likely COVID-19 cases, both in the US and worldwide, compared to reported data.